Kane Biotech Company Insiders

Kane Biotech Management Team Effectiveness

The company has return on total asset (ROA) of (0.5258) % which means that it has lost $0.5258 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (5.968) %, meaning that it generated substantial loss on money invested by shareholders. Kane Biotech's management efficiency ratios could be used to measure how well Kane Biotech manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 1.75 in 2026, whereas Return On Tangible Assets are likely to drop (1.87) in 2026. At this time, Kane Biotech's Total Current Assets are fairly stable compared to the past year. Intangible Assets is likely to climb to about 837 K in 2026, whereas Non Current Assets Total are likely to drop slightly above 1.3 M in 2026. Common Stock Shares Outstanding is likely to climb to about 166.4 M in 2026, whereas Net Loss is likely to drop (3.7 M) in 2026. Kane Biotech maintains a total of 167.35 Million outstanding shares. Kane Biotech holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Kane Biotech in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Kane Biotech, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Kane Biotech Workforce Comparison

Kane Biotech Benchmark Summation

Kane Biotech Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Kane Biotech often depends on how effective the management is. Kane Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Kane management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Kane management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Kane Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Kane Biotech. Check Kane Biotech's Beneish M Score to see the likelihood of Kane Biotech's management manipulating its earnings.

When running Kane Biotech's price analysis, check to measure Kane Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kane Biotech is operating at the current time. Most of Kane Biotech's value examination focuses on studying past and present price action to predict the probability of Kane Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kane Biotech's price. Additionally, you may evaluate how the addition of Kane Biotech to your portfolios can decrease your overall portfolio volatility.